The expression of HLA-E in the relapsed AML blasts in this patient with an expanded NKG2A-expressing CD56bright NK population suggests a potential evasion mechanism, in agreement with previous analysis of residual leukemic cells following allogeneic NK cell therapy (37). This evidence concerns the gene HLA-E and acute myeloid leukemia.